Cardioneuroablation (CNA) is a novel approach to treat patients with recurrent vasovagal syncope (VVS), targeting the ganglionated plexi around the atria and thus reducing the vagal input to the heart. We report a case of drug-refractory VVS following COVID-19 infection, successfully managed with cardioneuroablation.

JACC Case Reports Interim Editor-in-Chief 

Gilbert H. L. Tang, MD, MSc, MBA

CME Editor 

Kenneth A. Ellenbogen, MD

Author
Kelvin N.V. Bush, MD, FACC, CCDS
 

Important Dates

Date of Release: July 3, 2024 

Term of Approval/Date of CME/MOC Expiration: July 2, 2025